Pharmacotherapy During Percutaneous Coronary Interventions

Coronary Interventions ◽

10.5772/28149 ◽

2012 ◽

Author(s):

David C. ◽

Dmitriy N.

Keyword(s):

Percutaneous Coronary Interventions ◽

Coronary Interventions ◽

Percutaneous Coronary

Download Full-text

P2852 Superior clinical outcomes with abciximab versus eptifibatide: a contemporary, single centre, single operator, non-randomized comparison of 500 consecutive percutaneous coronary interventions

European Heart Journal ◽

10.1016/s0195-668x(03)95630-2 ◽

2003 ◽

Vol 24 (5) ◽

pp. 543

Author(s):

E DELIARGYRIS

Keyword(s):

Clinical Outcomes ◽

Percutaneous Coronary Interventions ◽

Single Centre ◽

Coronary Interventions ◽

Percutaneous Coronary ◽

Single Operator

Download Full-text

P1595 Independent and incremental prognostic value of Troponin T kinetics in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary interventions

European Heart Journal ◽

10.1016/s0195-668x(03)94733-6 ◽

2003 ◽

Vol 24 (5) ◽

pp. 292

Author(s):

A KARAVIDAS

Keyword(s):

Myocardial Infarction ◽

Prognostic Value ◽

Percutaneous Coronary Interventions ◽

St Segment Elevation ◽

Segment Elevation Myocardial Infarction ◽

Coronary Interventions ◽

Percutaneous Coronary ◽

Incremental Prognostic Value

Download Full-text

The Role of Standby Cardiopulmonary Bypass Support (CPS) for Elective Percutaneous Coronary Interventions

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)84129-0 ◽

1998 ◽

Vol 31 (2) ◽

pp. 97A

Author(s):

F Shawl

Keyword(s):

Cardiopulmonary Bypass ◽

Percutaneous Coronary Interventions ◽

Coronary Interventions ◽

Percutaneous Coronary

Download Full-text

Register of percutaneous coronary interventions. Are changes for 2015 — 2018 a casual splash of activities or system transformations?

UMJ Heart & Vessels ◽

10.30978/hv2019-3-12 ◽

2019 ◽

Vol 0 (3) ◽

pp. 12-33

Author(s):

М. Yu. Sokolov

Keyword(s):

Percutaneous Coronary Interventions ◽

Coronary Interventions ◽

Percutaneous Coronary

Download Full-text

Immune biomarkers of in-stent restenosis after percutaneous coronary interventions in myocardial infarction and stable angina patients

Российский иммунологический журнал ◽

10.31857/s102872210002391-5 ◽

2018 ◽

Vol 12(21) (3) ◽

pp. 255-260

Author(s):

N. Grachev ◽

◽

A. Semenikhin ◽

E. Turmova ◽

V. Rublev ◽

...

Keyword(s):

Myocardial Infarction ◽

Stable Angina ◽

Percutaneous Coronary Interventions ◽

Coronary Interventions ◽

Stent Restenosis ◽

Immune Biomarkers ◽

Percutaneous Coronary ◽

In Stent Restenosis

Download Full-text

Faculty Opinions recommendation of Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13200026.14542186 ◽

2011 ◽

Author(s):

John Ambrose

Keyword(s):

Renal Function ◽

Contrast Media ◽

Percutaneous Coronary Interventions ◽

Coronary Interventions ◽

Percutaneous Coronary ◽

Radiographic Contrast ◽

Radiographic Contrast Media ◽

Download Full-text

Faculty Opinions recommendation of Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: A report from the cathpci registry.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726098795.793532141 ◽

2017 ◽

Author(s):

Navin Kapur

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Cardiogenic Shock ◽

Temporal Trends ◽

Percutaneous Coronary Interventions ◽

Coronary Interventions ◽

Percutaneous Coronary

Download Full-text

Low-Molecular Weight Heparins in Percutaneous Coronary Interventions: Current Concepts, Problems, and Perspectives

Current Pharmaceutical Design ◽

10.2174/1381612043453342 ◽

2004 ◽

Vol 10 (4) ◽

pp. 375-386 ◽

Author(s):

Bentham Science Publisher Graf J. ◽

Bentham Science Publisher Janssens U.

Keyword(s):

Molecular Weight ◽

Low Molecular Weight ◽

Percutaneous Coronary Interventions ◽

Low Molecular Weight Heparins ◽

Coronary Interventions ◽

Percutaneous Coronary

Download Full-text

Optimal Use of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Patients Undergoing Percutaneous Coronary Interventions

Drugs ◽

10.2165/11595010-000000000-00000 ◽

2011 ◽

Vol 71 (15) ◽

pp. 2009-2030 ◽

Author(s):

H. Benjamin Starnes ◽

Ankit A. Patel ◽

George A. Stouffer

Keyword(s):

Platelet Glycoprotein ◽

Percutaneous Coronary Interventions ◽

Receptor Antagonists ◽

Coronary Interventions ◽

Percutaneous Coronary

Download Full-text

Difference in a decade: percutaneous coronary interventions in Australia

Internal Medicine Journal ◽

10.1111/imj.15150 ◽

2021 ◽

Vol 51 (1) ◽

pp. 138-139

Author(s):

Luke P. Dawson ◽

Stephen J. Duffy ◽

Diem Dinh ◽

David Clark ◽

Angela Brennan ◽

...

Keyword(s):

Percutaneous Coronary Interventions ◽

Coronary Interventions ◽

Percutaneous Coronary

Download Full-text